MBE - Second half revenue and profit are anticipated to be significantly stronger, with full year Revenues > $70 million and EBITDA of > $8 million.
EBITA anticipated >$8m, so how low this could go in terms of MC not share price ??
- Forums
- ASX - Day Trading
- Daytrading November 17 afternoon
Daytrading November 17 afternoon, page-60
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online